Provided by Tiger Trade Technology Pte. Ltd.

Evogene

1.08
+0.00050.05%
Volume:47.87K
Turnover:51.52K
Market Cap:9.42M
PE:-2.20
High:1.11
Open:1.08
Low:1.06
Close:1.08
52wk High:2.42
52wk Low:0.9300
Shares:8.72M
Float Shares:8.63M
Volume Ratio:0.03
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4910
EPS(LYR):-2.8935
ROE:-70.63%
ROA:-30.60%
PB:8.25
PE(LYR):-0.37

Loading ...

Press Release: Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board

Dow Jones
·
Yesterday

Evogene Subsidiary Biomica Signs Exclusive Licensing Agreement for BMC128 with Lishan Biotech

Reuters
·
Feb 04

Evogene Announces CFO Resignation and Finance Leadership Transition

TIPRANKS
·
Jan 16

Evogene CFO Yaron Eldad Resigns, Polina Ravzin Assumes CFO Duties

Reuters
·
Jan 16

Evogene Partners with Unravel Biosciences to Develop Remyelination Therapy for Demyelinating Disorders

Reuters
·
Jan 07

Evogene Appoints Dr. Olga Nissan as Vice President of Business Development

Reuters
·
Dec 30, 2025

Evogene Ltd. unveils company presentation highlighting proprietary innovation in real-world challenges

Reuters
·
Nov 27, 2025

Evogene Ltd. Earnings Call: Strategic Shifts and Optimism

TIPRANKS
·
Nov 22, 2025

Evogene Reports Q3 2025 Financial Results Amid Strategic Shift

TIPRANKS
·
Nov 20, 2025

Evogene posts $3.5 million revenue and $8.8 million operating loss for first nine months of 2025

Reuters
·
Nov 20, 2025

Casterra, Evogene Subsidiary, Partners with Fantini to Advance Mechanized Castor Farming

Reuters
·
Nov 11, 2025

Evogene Ltd. to Release Third Quarter 2025 Financial Results

Reuters
·
Nov 06, 2025

Evogene Ltd. to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

Reuters
·
Aug 28, 2025

Evogene Ltd reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 19, 2025

Evogene Q2 EPS $(0.50) Beats $(0.63) Estimate, Sales $884.000K Miss $930.000K Estimate

Benzinga
·
Aug 19, 2025

Evogene Ltd. Reports 39% Increase in H1 2025 Revenue to $3.2 Million, Driven by Higher Seed Sales

Reuters
·
Aug 19, 2025

Press Release: Evogene Reports Second Quarter 2025 Financial Results

Dow Jones
·
Aug 19, 2025

Evogene Ltd expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
Aug 15, 2025